Skip to content
10-Q

Quarterly Report

Evolutionary Genomics, Inc.

0001553350-21-000382

← back to feed
Filed
May 13, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2021 · Mar 31, 2021 5.88M sh
Long Term Debt Q1 2021 · Mar 31, 2021 $2.32M
Long Term Debt Q1 2021 · Dec 31, 2020 $2.25M
Cash And Equivalents Q1 2021 · Mar 31, 2021 $97.56K
Cash And Equivalents Q1 2021 · Dec 31, 2020 $215.84K
Cash And Equivalents Q1 2021 · Mar 31, 2020 $10.65K
Cash And Equivalents Q1 2021 · Dec 31, 2019 $45.44K
Current Liabilities Q1 2021 · Mar 31, 2021 $4.14K
Current Liabilities Q1 2021 · Dec 31, 2020 $3.16K
Total Liabilities Q1 2021 · Mar 31, 2021 $2.33M
Total Liabilities Q1 2021 · Dec 31, 2020 $2.25M
Current Assets Q1 2021 · Mar 31, 2021 $155.85K
Current Assets Q1 2021 · Dec 31, 2020 $277.59K
Total Assets Q1 2021 · Mar 31, 2021 $3.61M
Total Assets Q1 2021 · Dec 31, 2020 $3.99M
Revenue Q1 2021 · Mar 31, 2021 $0
Revenue Q1 2021 · Mar 31, 2020 $12.5K
Operating Cash Flow Q1 2021 · Mar 31, 2020 −$34.79K
Stockholders Equity Q1 2021 · Mar 31, 2020 −$520.61K
Stockholders Equity Q1 2021 · Dec 31, 2019 −$333.73K
Sga Expense Q1 2021 · Mar 31, 2020 $56.67K
Rd Expense Q1 2021 · Mar 31, 2020 $93.22K
Net Income Q1 2021 · Mar 31, 2020 −$241.82K
Operating Income Q1 2021 · Mar 31, 2020 −$229.82K